Clinical and Prognostic Value of PET/CT Imaging with Combination of 68Ga-DOTATATE and 18F-FDG in Gastroenteropancreatic Neuroendocrine Neoplasms

Clinical and Prognostic Value of PET/CT Imaging with Combination of 68Ga-DOTATATE and 18F-FDG in Gastroenteropancreatic Neuroendocrine Neoplasms

Background. To evaluate the clinical and prognostic value of PET/CT with combination of 68Ga-DOTATATE and 18F-FDG in gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs). Method. 83 patients of GEP-NENs who underwent 68Ga-DOTATATE and 18F-FDG PET/CT were enrolled between June 2013 and December...

Full description

Bibliographic Details
Main Authors:	Panpan Zhang, Jiangyuan Yu, Jie Li, Lin Shen, Nan Li, Hua Zhu, Shizhen Zhai, Yan Zhang, Zhi Yang, Ming Lu
Format:	Article
Language:	English
Published:	Hindawi-Wiley 2018-01-01
Series:	Contrast Media & Molecular Imaging
Online Access:	http://dx.doi.org/10.1155/2018/2340389

Similar Items

Efficacy of Galium-68 DOTATATE PET/CT in the Detection of Metastasis Rate of Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors
by: Halil Komek, et al.
Published: (2019-06-01)

Evaluation of 18F-AlF-NOTA-octreotide for imaging neuroendocrine neoplasms: comparison with 68Ga-DOTATATE PET/CT
by: Jiale Hou, et al.
Published: (2021-06-01)

Comparison of 18F‐FDG PET/CT and 68Ga‐DOTATATE PET/CT in the Targeted Imaging of Culprit Tumors Causing Osteomalacia
by: Hao‐nan Yu, et al.
Published: (2021-05-01)

Identification and characterization of myocardial metastases in neuroendocrine tumor patients using 68Ga-DOTATATE PET-CT
by: Wolfgang G. Kunz, et al.
Published: (2018-09-01)

Metastatic urinary bladder paraganglioma on Ga-68 DOTATATE PET/CT
by: Andrew Ko, BSA, et al.
Published: (2021-09-01)

Pulmonary large cell neuroendocrine carcinoma (LCNEC) with confirmed liver metastases negative on 18F-FDG and 68Ga-DOTATATE PET
by: Gaia Ninatti, et al.
Published: (2020-12-01)

Molecular imaging of a glucagonoma with 18F-FDG PET/CT and 68Ga-DOTATATE PET/CT imaging: A case report and review of the literature
by: Ahmed Fathala, MD, et al.
Published: (2020-01-01)

Gastrointestinal neuroendocrine tumor with discordant metastatic disease on 111In-pentetreotide SPECT/CT, 18F-DOPA PET/CT and 68Ga-HA-DOTATATE PET/CT
by: Abele, J., et al.
Published: (2022)

Incidental primary breast cancer detected on surveillance 68Ga-DOTATATE PET/CT in a patient with metastatic neuroendocrine carcinoma
by: Emily B. Ambinder, MD, et al.
Published: (2020-08-01)

Prognostic factors of patients with gastroenteropancreatic neuroendocrine neoplasms
by: Pao-Yuan Huang, et al.
Published: (2018-11-01)

68Ga-DOTATATE PET/CT imaging of indeterminate pulmonary nodules and lung cancer.
by: Ronald Walker, et al.
Published: (2017-01-01)

Research Progress of Gastroenteropancreatic Neuroendocrine Neoplasm
by: LUO Wenhao, et al.
Published: (2018-01-01)

Diagnostic Utility of PET CT in Thymic Tumours with Emphasis on 68Ga-DOTATATE PET CT in Thymic Neuroendocrine Tumour - Experience at a Tertiary Level Hospital in India
by: Julie Hephzibah, et al.
Published: (2014-09-01)

Diagnostic efficiency of 68Ga-DOTATATE PET/CT as compared to 99mTc-Octreotide SPECT/CT and conventional morphologic modalities in neuroendocrine tumors
by: Babak Fallahi, et al.
Published: (2019-06-01)

Tumour-to-liver ratio determined by [68Ga]Ga-DOTA-TOC PET/CT as a prognostic factor of lanreotide efficacy for patients with well-differentiated gastroenteropancreatic-neuroendocrine tumours
by: Yong-il Kim, et al.
Published: (2020-06-01)

Somatostatin receptor scintigraphy with <sup>68</sup>Ga-DOTATATE PET/CT: initial experience in Cuba
by: Juan P. Oliva González
Published: (2017-06-01)

68Ga DOTATATE Uptake in Hemangioma Simulating Metastasis on PET Imaging
by: Bart Vertenten, et al.
Published: (2019-06-01)

68Ga-DOTATATE PET/CT Compared with 131I-MIBG SPECT/CT in the Evaluation of Neural Crest Tumors
by: Pezhman Shahrokhi, et al.
Published: (2020-01-01)

The role of [68 Ga]Ga-DOTATATE PET/CT in wild-type KIT/PDGFRA gastrointestinal stromal tumours (GIST)
by: Luigi Aloj, et al.
Published: (2021-01-01)

Gastroenteropancreatic neuroendocrine neoplasms: genes, therapies and models
by: Kenta Kawasaki, et al.
Published: (2018-02-01)

Impact of PET data driven respiratory motion correction and BSREM reconstruction of 68Ga-DOTATATE PET/CT for differentiating neuroendocrine tumors (NET) and intrapancreatic accessory spleens (IPAS)
by: Virginia Liberini, et al.
Published: (2021-01-01)

Long‐Term Survival and Value of <sup>18</sup>F‐FDG PET/CT in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with Second Peptide Receptor Radionuclide Therapy Course with <sup>177</sup>Lu‐DOTATATE
by: Margarida Rodrigues, et al.
Published: (2021-03-01)

Recurrence pattern analysis after [68Ga]-DOTATATE-PET/CT -planned radiotherapy of high-grade meningiomas
by: Barbara Zollner, et al.
Published: (2018-06-01)

Dual Tracer 68Ga-DOTATOC and 18F-FDG PET Improve Preoperative Evaluation of Aggressiveness in Resectable Pancreatic Neuroendocrine Neoplasms
by: Paola Mapelli, et al.
Published: (2021-01-01)

68Ga-DOTATATE PET imaging in clinically non-functioning pituitary macroadenomas
by: Tessel M. Boertien, et al.
Published: (2020-02-01)

Clinicopathological features and lymph node and distant metastasis patterns in patients with gastroenteropancreatic mixed neuroendocrine‐non‐neuroendocrine neoplasm
by: Panpan Zhang, et al.
Published: (2021-07-01)

Assessment and State of Nutrition of Patients with Gastroenteropancreatic Neuroendocrine Neoplasms
by: Justyna Kikut, et al.
Published: (2020-06-01)

Inflammation-related cytokines and their roles in gastroenteropancreatic neuroendocrine neoplasms
by: Davorka Herman Mahečić, et al.
Published: (2020-03-01)

68Ga-DOTATATE PET-CT as a tool for radiation planning and evaluating treatment responses in the clinical management of meningiomas
by: Emily S. Kowalski, et al.
Published: (2021-08-01)

Loss of expression and prognosis value of alpha-internexin in gastroenteropancreatic neuroendocrine neoplasm
by: Yuhong Wang, et al.
Published: (2018-06-01)

Incidental Finding of Squamous Cell Carcinoma on a 68Ga-DOTATATE PET Scan
by: Sanjana Mullangi MD, et al.
Published: (2021-07-01)

Initial Experience with <sup>64</sup>Cu-DOTATATE Digital PET of Patients with Neuroendocrine Neoplasms: Comparison with Analog PET
by: Mathias Loft, et al.
Published: (2021-02-01)

The Use of 68Ga-DOTATATE PET/CT in the Non-invasive Diagnosis of Optic Nerve Sheath Meningioma: A Case Report
by: Karine A. Al Feghali, et al.
Published: (2018-10-01)

Automated liver lesion detection in 68Ga DOTATATE PET/CT using a deep fully convolutional neural network
by: Jonathan Wehrend, et al.
Published: (2021-10-01)

Advances and Current Concepts in the Medical Management of Gastroenteropancreatic Neuroendocrine Neoplasms
by: Krystallenia I. Alexandraki, et al.
Published: (2017-01-01)

Neuroendocrine neoplasms: a brief overview emphasizing gastroenteropancreatic tumors
by: José Manuel Lopes
Published: (2017-03-01)

Clinicopathological heterogeneity between primary and metastatic sites of gastroenteropancreatic neuroendocrine neoplasm
by: Huiying Shi, et al.
Published: (2020-09-01)

Comparison of 68Ga-DOTANOC and 18F-FDG PET-CT Scans in the Evaluation of Primary Tumors and Lymph Node Metastasis in Patients With Rectal Neuroendocrine Tumors
by: Zhihao Zhou, et al.
Published: (2021-09-01)

Diagnostic utility of 68Ga-citrate and 18FDG PET/CT in sarcoidosis patients
by: Cuneyt Tetikkurt, et al.
Published: (2020-12-01)

Grading of Neuroendocrine Carcinomas: Correlation of 68Ga-PET/CT Scan with Tissue Biomarkers
by: Chiara Liverani, et al.
Published: (2018-01-01)